scispace - formally typeset
D

Dolores Vilella

Researcher at Merck & Co.

Publications -  8
Citations -  818

Dolores Vilella is an academic researcher from Merck & Co.. The author has contributed to research in topics: Farnesyl Protein Transferase & Integrase. The author has an hindex of 8, co-authored 8 publications receiving 772 citations.

Papers
More filters
Journal ArticleDOI

Discovery of a small molecule insulin mimetic with antidiabetic activity in mice.

TL;DR: The discovery of a nonpeptidyl fungal metabolite (L-783,281) that acted as an insulin mimetic in several biochemical and cellular assays demonstrates the feasibility of discovering novel insulin receptor activators that may lead to new therapies for diabetes.
Journal ArticleDOI

Structure and absolute stereochemistry of HIV-1 integrase inhibitor integric acid. A novel eremophilane sesquiterpenoid produced by a Xylaria sp.

TL;DR: Integric acid, a novel eremophilane sesquiterpenoid, was discovered from the screening of natural product libraries and inhibited 3′ -end processing, strand transfer and disintegration reactions catalyzed by HIV-1 integrase with IC50 values of 3–10 μM.
Journal ArticleDOI

Inhibitors of farnesylation of Ras from a microbial natural products screening program

TL;DR: Ten different families of compounds are identified, all of which selectively inhibit FPTase with a variety of mechanisms, which originated from the fermentations of a number of microorganisms, either actinomycetes or fungi, isolated from different substrates collected in tropical and temperate areas.